0
Poster Presentations: Wednesday, November 3, 2010 |

The Incidence of Mycobacterium Other Than Tuberculosis Isolated in Specimens Suspected of Tuberculosis in a Tertiary Hospital in the Philippines FREE TO VIEW

Julie Christie G. Visperas, MD; Jose Manuel T. Rañola, III, MD; Maria Rhona G. Bergantin, MD; Jose Hesron D. Morfe, MD
Author and Funding Information

University of Santo Tomas Hospital; Center for Respiratory Medicine, Manila, Philippines



Chest. 2010;138(4_MeetingAbstracts):682A. doi:10.1378/chest.10141
Text Size: A A A
Published online

Abstract

PURPOSE: Mycobacterium other than tuberculosis (MOTT) are mycobacterial species that may cause human disease, but do not cause tuberculosis. It is an uncommon organism that has been reported in 2 out of 100,000 persons in the United States. In our institution, the incidence of a positive MOTT culture is not known. It is the objective of this study to determine the prevalence rate of MOTT in a referral university hospital in the Philippines for which tuberculosis is suspected.

METHODS: Specimens submitted for culture and sensitivity studies for Mycobacterium tuberculosis for which isolates of Mycobacterium other than tuberculosis grew using the BACTEC (Becton-Dickinson) method or Mycobacteria Growth Indicator Tube (MGIT) were included in the study.

RESULTS: For the period of January 1, 2003 up to June 30, 2009, there were 2,714 specimens submitted for Mycobaterium culture, of which 59 (2.17%) were isolated for MOTT. Majority of which were from respiratory sources (n=48, sputum; 3, bronchial washing; and 1, bronchial aspirate) while minority were from varied sources (n= 2, urine; 1, lymph node; 1 lung tissue; 1, mediastinal aspirate; 1 subcutaneous tissue; 1, CSF).

CONCLUSION: There is a low incidence of positive culture for Mycobaterium other than tuberculosis in our institution.

CLINICAL IMPLICATIONS: Although there is a low incidence of MOTT in patients suspected to have tuberculosis, species identification in Mycobacterium is still important because of difference in treatment regimen.

DISCLOSURE: Julie Christie Visperas, No Financial Disclosure Information; No Product/Research Disclosure Information

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543